----
Forecast & Rating4 analysts currently cover NRX Therapeutics, of which 4 give a positive rating. The average price target is $38.50, about 1209.5% upside from the current price of $2.94. Coverage is limited, so the data is for reference only. Data as of Oct 1, 2026; this does not constitute investment advice.
Oct 1, 2026Price forecast
$38.501209.52%
Forecast & RatingStrong buy
4analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 4
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong sell
- 0
Target price forecast
Forecast dateOct 5, 2026
Forecast met0.0%
Stock price$2.94
Avg. target$38.5
High target$50
Low target$10
- Avg. target
- $38.5
- High target
- $50
- Low target
- $10
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.
